Aromasin 25 MG Tablet contains Exemestane 25mg, a branded steroidal aromatase inactivator approved for adjuvant and advanced breast cancer treatment in postmenopausal women with estrogen receptor-positive tumors.

How It Works: Exemestane irreversibly inactivates aromatase (CYP19A1), the enzyme that converts androgens to estrogens in peripheral tissues, leading to sustained near-complete estrogen suppression in postmenopausal women.

Common Uses: Early breast cancer in postmenopausal women after 2–3 years of tamoxifen (sequential strategy), advanced breast cancer after tamoxifen failure, and prevention in high-risk postmenopausal women.

Administration: Take one tablet once daily after a meal. Consistent daily dosing is required for effective estrogen suppression. Duration guided by oncologist.

Storage: Store below 25°C in a dry location. Keep in original packaging away from moisture and children.

Disclaimer: This product requires a valid prescription. Consult a licensed oncologist before use. This information is for educational purposes only.